Mirae Asset Global ETFs Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353K	Buy	4,373 +100	+2%	+$7.53K	﹤0.01%	2186
2026 Q1	$310K	Sell	4,273 -61	-1%	-$4.81K	﹤0.01%	2129
2025 Q4	$342K	Sell	4,334 -2,097	-33%	-$158K	﹤0.01%	2085
2025 Q3	$413K	Sell	6,431 -640	-9%	-$31.2K	﹤0.01%	1956
2025 Q2	$281K	Sell	7,071 -1,135	-14%	-$37.1K	﹤0.01%	2100
2025 Q1	$256K	Sell	8,206 -1,244	-13%	-$40.7K	﹤0.01%	2191
2024 Q4	$330K	Buy	9,450 +1,625	+21%	+$60.7K	﹤0.01%	2118
2024 Q3	$320K	Buy	7,825 +1,468	+23%	+$68.3K	﹤0.01%	2134
2024 Q2	$300K	Buy	+6,357	New	+$261K	﹤0.01%	2067

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IONS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ionis Pharmaceuticals (IONS) stake by 2.3% in Q2 2026, buying an estimated $7.53K and bringing the position to 4,373 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Mirae Asset Global ETFs Holdings first reported a position in IONS in Q2 2024 and has held it in 9 quarters since. The position peaked at $413K in Q3 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Mirae Asset Global ETFs Holdings held 4,373 shares of Ionis Pharmaceuticals worth $353K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 100 Ionis Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
Ionis Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2186 holding.
Mirae Asset Global ETFs Holdings first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Ionis Pharmaceuticals position peaked at $413K in Q3 2025.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.